47 results
6-K
EX-10.1
IPA
ImmunoPrecise Antibodies Ltd
23 Feb 24
Current report (foreign)
5:29pm
option, stock purchase, or equity incentive plans. The Company does not have pending before the Commission any request for confidential treatment … equity awards pursuant to any employee or director share option, incentive or benefit plan, share purchase or ownership plan, long-term incentive plan
424B5
IPA
ImmunoPrecise Antibodies Ltd
7 Dec 23
Prospectus supplement for primary offering
4:53pm
incentive plans or issue additional warrants, you may experience further dilution of your investment. See the section entitled "Dilution" below for a more
6-K
EX-10.1
IPA
ImmunoPrecise Antibodies Ltd
6 Dec 23
Current report (foreign)
5:19pm
of options to purchase the Company's Common Shares issued under an equity incentive plan of the Company or an employment arrangement described
424B5
IPA
ImmunoPrecise Antibodies Ltd
5 Dec 23
Prospectus supplement for primary offering
4:02pm
grant additional options or other awards under our equity incentive plans or issue additional warrants, you may experience further dilution of your
6-K
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
20 Oct 23
Current report (foreign)
2:56pm
and reviewed annually by the Remuneration and Nomination Committee.
Short-term cash incentives
The Company provides cash incentive payments based … on the financial performance of the Company and the individual performance of executives. The target incentive for the CEO is 100% of base salary with USD200,000
6-K
EX-99.1
zaugb
18 Sep 23
Statement of Executive Compensation
2:47pm
6-K
EX-10.1
ds9o1
15 Aug 23
Current report (foreign)
5:50pm
40-F
qlb u92fs
10 Jul 23
Annual report (Canada)
4:32pm
40-F
EX-99.2
fckmysj
10 Jul 23
Annual report (Canada)
4:32pm
6-K
EX-99.1
uzd1cvmo1ik4idq2d6lh
24 Apr 23
Current report (foreign)
10:01am
6-K
EX-99.2
mn79kn1s
17 Nov 22
Current report (foreign)
9:36am
6-K
EX-99.1
158ofy
1 Nov 22
Current report (foreign)
7:07pm
40-F
EX-99.2
1ba56bsds7j7suqvj9a
29 Jul 22
Annual report (Canada)
9:04am
6-K
EX-99.2
34g419ziuscohucum
14 Apr 22
Current report (foreign)
10:18am
6-K
EX-99.1
bjiao 353ndpb5ba5zdx
12 Nov 21
Current report (foreign)
8:58am
6-K
EX-99.2
rrums ats5c
13 Oct 21
ImmunoPrecise Announces At-The-Market Facility of up to US$50 Million
5:31pm
40-F
EX-99.2
qujbe1jikum4y re3e
28 Jul 21
Annual report (Canada)
8:01am
S-8
EX-4.3
o20futwdrw9t midi5z
2 Jun 21
Registration of securities for employees
5:26pm
6-K
EX-99.2
4w475az
18 Mar 21
Current report (foreign)
6:05am
6-K
EX-99.1
tpv ms5rkdypc
18 Mar 21
Current report (foreign)
6:05am